GLOBUS MED INC's ticker is GMED and the CUSIP is 379577208. A total of 424 filers reported holding GLOBUS MED INC in Q3 2023. The put-call ratio across all filers is 0.34 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $875,876 | +52.7% | 17,641 | +83.1% | 0.01% | +50.0% |
| Q2 2023 | $573,549 | -4.9% | 9,633 | -9.5% | 0.01% | -11.1% |
| Q1 2023 | $603,159 | -24.0% | 10,649 | -0.3% | 0.01% | -30.8% |
| Q4 2022 | $793,501 | +38.0% | 10,684 | +10.6% | 0.01% | +18.2% |
| Q3 2022 | $575,000 | +1.6% | 9,656 | -4.3% | 0.01% | 0.0% |
| Q2 2022 | $566,000 | -14.5% | 10,085 | +12.3% | 0.01% | 0.0% |
| Q1 2022 | $662,000 | -0.7% | 8,977 | -2.8% | 0.01% | +10.0% |
| Q4 2021 | $667,000 | -3.8% | 9,235 | +2.1% | 0.01% | -23.1% |
| Q3 2021 | $693,000 | -3.6% | 9,041 | -2.5% | 0.01% | 0.0% |
| Q2 2021 | $719,000 | +43.5% | 9,274 | +14.1% | 0.01% | +18.2% |
| Q1 2021 | $501,000 | -4.2% | 8,131 | +1.3% | 0.01% | 0.0% |
| Q4 2020 | $523,000 | +33.1% | 8,024 | +1.1% | 0.01% | +10.0% |
| Q3 2020 | $393,000 | +20.6% | 7,934 | +16.2% | 0.01% | +25.0% |
| Q2 2020 | $326,000 | – | 6,830 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Consonance Capital Management LP | 373,254 | $26,949,000 | 17.58% |
| Next Capital Management LLC | 111,098 | $8,021,000 | 5.42% |
| Sterling Investment Advisors, Ltd. | 188,123 | $13,582,000 | 3.82% |
| Integral Health Asset Management, LLC | 180,000 | $12,996,000 | 3.60% |
| Pembroke Management, LTD | 602,447 | $43,497,000 | 3.19% |
| Godshalk Welsh Capital Management, Inc. | 73,435 | $5,302,000 | 3.02% |
| XXEC, Inc. | 51,925 | $3,420,000 | 2.92% |
| Sivik Global Healthcare LLC | 75,000 | $5,415,000 | 2.32% |
| PARADIGM CAPITAL MANAGEMENT INC/NY | 654,100 | $47,226,000 | 2.11% |
| Van Berkom & Associates Inc. | 929,856 | $67,136,000 | 1.98% |